Accelerated infected wound healing by probiotic-based living microneedles with long-acting antibacterial effect
Open Access
- 1 August 2024
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 38, 292-304
Abstract
Delays in infected wound healing are usually a result of bacterial infection and local inflammation, which imposes a significant and often underappreciated burden on patients and society. Current therapies for chronic wound infection generally suffer from limited drug permeability and frequent drug administration, owing to the existence of a wound biofilm that acts as a barrier restricting the entry of various antibacterial drugs. Here, we report the design of a biocompatible probiotic-based microneedle (MN) patch that can rapidly deliver beneficial bacteria to wound tissues with improved delivery efficiency. The probiotic is capable of continuously producing antimicrobial substances by metabolizing introduced glycerol, thereby facilitating infected wound healing through long-acting antibacterial and anti-inflammatory effects. Additionally, the beneficial bacteria can remain highly viable (>80 %) inside MNs for as long as 60 days at 4 °C. In a mouse model of Staphylococcus aureus-infected wounds, a single administration of the MN patch exhibited superior antimicrobial efficiency and wound healing performance in comparison with the control groups, indicating great potential for accelerating infected wound closure. Further development of live probiotic-based MN patches may enable patients to better manage chronically infected wounds.Keywords
Funding Information
- Zhongnan Hospital of Wuhan University
- National Natural Science Foundation of China
This publication has 56 references indexed in Scilit:
- Negative pressure wound therapy versus conventional wound dressings in treatment of open fractures: A systematic review and meta-analysisInternational Journal of Surgery, 2018
- Role of Lactobacillus reuteri in Human Health and DiseasesFrontiers in Microbiology, 2018
- Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of actionVirulence, 2018
- Soybean protein-based microparticles for oral delivery of probiotics with improved stability during storage and gut resistanceFood Chemistry, 2018
- Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin deliveryProceedings of the National Academy of Sciences, 2015
- Efficient poly(3-hydroxypropionate) production from glycerol using Lactobacillus reuteri and recombinant Escherichia coli harboring L. reuteri propionaldehyde dehydrogenase and Chromobacterium sp. PHA synthase genesBioresource Technology, 2015
- Microneedles for drug delivery: trends and progressDrug Delivery, 2014
- Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problemTherapeutic Advances in Drug Safety, 2014
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot InfectionsaClinical Infectious Diseases, 2012
- Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteriaBMC Microbiology, 2007